{"id":5471,"date":"2023-12-01T05:24:38","date_gmt":"2023-12-01T05:24:38","guid":{"rendered":"https:\/\/event.roseliassociates.com\/nci-dcb-somatic-mutations-ws-2024\/?p=5471"},"modified":"2023-12-01T05:27:14","modified_gmt":"2023-12-01T05:27:14","slug":"jesse-boehm-phd","status":"publish","type":"post","link":"https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/2023\/12\/01\/jesse-boehm-phd\/","title":{"rendered":"Jesse Boehm, PhD"},"content":{"rendered":"<p><img decoding=\"async\" class=\"lazyload alignnone size-full wp-image-5472\" src=\"http:\/\/event.roseliassociates.com\/nci-dcb-somatic-mutations-ws-2024\/wp-content\/uploads\/sites\/80\/2023\/12\/Boehm.png\" data-orig-src=\"http:\/\/event.roseliassociates.com\/nci-dcb-somatic-mutations-ws-2024\/wp-content\/uploads\/sites\/80\/2023\/12\/Boehm.png\" alt=\"\" width=\"300\" height=\"300\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27300%27%20height%3D%27300%27%20viewBox%3D%270%200%20300%20300%27%3E%3Crect%20width%3D%27300%27%20height%3D%27300%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-srcset=\"https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-content\/uploads\/sites\/80\/2023\/12\/Boehm-66x66.png 66w, https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-content\/uploads\/sites\/80\/2023\/12\/Boehm-150x150.png 150w, https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-content\/uploads\/sites\/80\/2023\/12\/Boehm-200x200.png 200w, https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-content\/uploads\/sites\/80\/2023\/12\/Boehm.png 300w\" data-sizes=\"auto\" data-orig-sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>Principal Investigator, MIT<\/p>\n<p>Chief Science Officer, Break Through Cancer<\/p>\n<p>Dr. Boehm maintains a research lab at MIT\u2019s Koch Institute focused on bringing the power of functional genomics to bear on living samples from cancer patients with particular emphasis on rare and underrepresented tumors. The team partners with patients across the country, enabling them to donate living tissue for research, creates organoid and cell models and leverages these living tissues to prototype precision functional genomics &#8211; based technologies as part of a push towards showing proof-of-concept for new functional diagnostic methods for individual cancer patients.\u00a0Dr. Boehm is also the Chief Science Officer of Break Through Cancer, a novel foundation dedicated to urgently reimagining how we cure cancer by harnessing the power of extraordinary partnerships. Break Through Cancer unites leading cancer institutions jointly focused on overcoming barriers impossible for any single organization to solve.\u00a0Before transitioning to MIT, Dr. Boehm previously spent 14 years in the Broad Institute\u2019s Cancer Program, most recently as an Institute Scientist and Scientific Director of the Cancer Dependency Map project. As the Director of the Broad\u2019s Cancer Model Development Center (part of the National Cancer Institute\u2019s Human Cancer Models Initiative), he led his laboratory in developing a scalable capacity to convert patient tumors into organoids and other cell models.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Principal Investigator, MIT Chief Science Officer, Break Through Cancer Dr. Boehm maintains a research lab at MIT\u2019s Koch Institute focused on bringing the power of functional genomics to bear on living samples from cancer patients with particular emphasis on rare and underrepresented tumors. The team partners with patients across the country, enabling them to donate [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":5472,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[],"class_list":["post-5471","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-creative"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-json\/wp\/v2\/posts\/5471","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-json\/wp\/v2\/comments?post=5471"}],"version-history":[{"count":1,"href":"https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-json\/wp\/v2\/posts\/5471\/revisions"}],"predecessor-version":[{"id":5473,"href":"https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-json\/wp\/v2\/posts\/5471\/revisions\/5473"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-json\/wp\/v2\/media\/5472"}],"wp:attachment":[{"href":"https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-json\/wp\/v2\/media?parent=5471"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-json\/wp\/v2\/categories?post=5471"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/event.roseliassociates.com\/nci-dcb-stromal-mutations-ws-2024\/wp-json\/wp\/v2\/tags?post=5471"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}